424B3 1 a2148974z424b3.htm 424B3
QuickLinks -- Click here to rapidly navigate through this document

Filed Pursuant to
Rule 424(b)(3) and (c)
File No. 333-115516


Prospectus Supplement
Dated December 21, 2004

InterMune, Inc.
$170,000,000 .25% Convertible Senior Notes Due 2011

        This prospectus supplement supplements the prospectus, dated October 27, 2004, of InterMune, Inc. ("InterMune") relating to the resale by selling securityholders of InterMune's .25% Convertible Senior Notes Due March 1, 2011. This prospectus supplement should be read in conjunction with the prospectus, and is qualified by reference to the prospectus, except to the extent that the information presented herein supersedes the information contained in the prospectus. This prospectus supplement is not complete without, and may not be delivered or utilized except in connection with, the prospectus, including any amendments or supplements thereto.

        Investing in our securities involves a high degree of risk. See "Risk Factors" beginning on page 5 of the prospectus.

        Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

        The table appearing on pages 62 through 64 of the prospectus under the caption "Selling Securityholders" is amended and restated to include the following securityholders:



SELLING SECURITYHOLDERS

        We originally issued and sold the notes to the initial purchasers in transactions exempt from the registration requirements of the Securities Act, and the initial purchasers immediately resold the notes to persons they reasonably believed to be qualified institutional buyers. Selling holders, including their transferees, pledgees or donees or their successors, may from time to time offer and sell pursuant to this prospectus any or all of the notes and common stock into which the notes are convertible.

        The following table sets forth information with respect to the selling holders and the principal amounts of notes beneficially owned by each selling holder that may be offered under this prospectus. The information is based on information provided by or on behalf of the selling holders. The selling holders may offer all, some or none of the notes or common stock into which the notes are convertible. Because the selling holders may offer all or some portion of the notes or the common stock, no estimate can be given as to the amount of the notes or the common stock that will be held by the selling holders upon termination of any sales: the table below assumes that all selling holders will sell all of their notes or common stock, unless otherwise indicated. In addition, the selling holders identified below may have sold, transferred or otherwise disposed of all or a portion of their notes or common stock since the date on which they provided the information regarding their notes and common stock in transactions exempt from the registration requirements of the Securities Act. No offer or sale under this prospectus may be made by a security holder unless that security holder is listed in the table below.

 
   
   
   
   
  Common Stock
Beneficially Owned After
Completion of the
Offering

 
   
   
   
  Principal
Amount of
Notes Owned
After
Completion of
Offering

 
  Principal Amount
of Notes
Beneficially Owned
and Offered(2)

  Common
Stock
Beneficially
Owned(3)

   
Name(1)

  Common
Stock
Offered

  Number of
Shares

  Percentage
Ownership

Alexandra Global Master Fund Ltd.   $ 10,000,000   462,283   462,283       *
Baker Biotech Fund I, L.P.   $ 2,945,000   136,142   136,142       *
Baker Biotech Fund II, L.P.   $ 2,747,000   126,989   126,989       *
Baker Bros. Investments, L.P.   $ 308,000   14,238   14,238       *
BNP Paribas Equity Strategies, SNC   $ 7,096,000   328,061 (4) 328,036     25   *
Cheyne Fund LP   $ 1,037,000   47,938   47,938       *
Cheyne Leveraged Fund LP   $ 789,000   36,474   36,474       *
CIP Limited Duration Company   $ 112,000   5,177   5,177       *
Citadel Credit Trading Ltd.   $ 690,000   31,897   31,897       *
Citadel Equity Fund Ltd.   $ 5,310,000   245,472   245,472       *
CooperNeff Convertible Strategies (Cayman) Master Fund, LP   $ 7,526,000   347,914   347,914       *
Credit Suisse First Boston LLC     250,000   11,557   11,557       *
Credit Suisse First Boston Europe Ltd.(5)     9,000,000   416,054   416,054       *
CS Alternative Strategy Ltd.   $ 62,000   2,866   2,866       *
Deutsche Bank Securities Inc.(6)   $ 650,000   30,048   30,048       *
DKR Saturn Event Driven Holding Fund Ltd.   $ 9,000,000   614,554 (7) 416,054     198,500   *
DKR Saturn Multi-Strategy Holding Fund Ltd.   $ 9,000,000   456,354 (8) 416,054     40,300   *
                           

2


FrontPoint Convertible Arbitrage Fund, L.P.   $ 3,500,000   161,799   161,799       *
Grace Convertible Arbitrage Fund, Ltd.   $ 5,000,000   231,141   231,141       *
Guggenheim Portfolio Co. XV, LLC   $ 500,000   23,114   23,114       *
Highbridge International LLC   $ 9,000,000   416,054   416,054       *
KBC Convertible MAC28 Ltd.   $ 520,000   24,038   24,038       *
KBC Convertible Opportunities Fund   $ 6,500,000   300,483   300,483       *
KBC Melody AIM Ltd.   $ 390,000   18,029   18,029       *
KBC Multi Strategy Arbitrage Fund   $ 5,590,000   258,416   258,416       *
KDC Convertible Arbitrage Fund L.P.   $ 1,000,000   46,228   46,228       *
Lyxor/Convertible Arbitrage Fund Limited   $ 1,280,000   59,172   59,172       *
Nisswa Master Fund Ltd.   $ 500,000   23,114   23,114       *
Polaris Vega Fund L.P.   $ 500,000   23,114   23,114       *
RCG Baldwin, LP   $ 1,000,000   46,228   46,228       *
Ramius Capital Group   $ 250,000   11,557   11,557       *
Ramius Master Fund, Ltd.   $ 2,750,000   127,127   127,127       *
RCG Halifax Master Fund, Ltd.   $ 250,000   11,557   11,557       *
RCG Latitude Master Fund, Ltd.   $ 4,500,000   208,027   208,027       *
RCG Multi Strategy Master Fund Ltd.   $ 750,000   34,671   34,671       *
S.A.C. Arbitrage Fund, LLC   $ 500,000   42,133 (4) 23,114     19,019   *
Salomon Brothers Asset Management Inc.   $ 28,500,000   1,049,963 (9) 1,317,506     92,457   *
Saranac Capital Management L.P.   $ 18,250,000   843,666   843,666       *
Singlehedge US Convertible Arbitrage Fund   $ 1,740,000   80,437   80,437       *
Sturgeon Limited   $ 1,258,000   58,155   58,155       *
Sunrise Partners Limited Partnership   $ 1,125,000   77,306 (4) 52,006     25,300   *
Tewksbury Investment Fund Ltd.   $ 1,000,000   46,228   46,228       *
Value Line Convertible Fund, Inc.   $ 200,000   9,245   9,245       *
Xavex Convertible Arbitrage 5 Fund   $ 1,000,000   46,228   46,228       *
                           

3


Unidentified Selling Securityholders   $ 6,125,000     283,164       *
   
 
 
 
 
 
Total   $ 170,000,000       7,858,811     375,601   *
   
 
 
 
 
 

*
Less than one percent.

(1)
Information about other selling holders will be set forth in post-effective amendments, if required.

(2)
The total principal amount of notes and shares of common stock issuable upon conversion of notes listed in the table may be more than $170,000,000 and 7,858,811 shares, respectively, because certain of the selling securityholders may have sold, transferred or otherwise disposed of all or a portion of their notes in transactions exempt from the registration requirements of the Securities Act since the date on which they provided information regarding their notes for inclusion in this table. The maximum principal amount of notes and number of shares of common stock issuable upon conversion of the notes that may be sold under this prospectus will not exceed $170,000,000 and 7,858,811 shares, respectively.

(3)
Unless otherwise noted, represents shares of common stock issuable upon conversion of the notes.

(4)
Includes shares of common stock held.

(5)
The selling securityholder is an affiliate of a broker dealer who purchased the securities in the ordinary course of business and at the time of the purchase of the securities to be resold, the selling securityholder had no agreement or understandings, directly or indirectly, with any person to distribute the securities.

(6)
Because Deutsche Banc Securities Inc. ("Deutsche Banc") is a broker-dealer, it is deemed to be an "underwriter" within the meaning of Section 2(11) of the Securities Act. As a result, any profits on the sale of the securities by Deutsche Banc, and any discounts, commissions or concessions received by Deutsche Banc, will be deemed to be underwriting discounts and commissions under the Securities Act.

(7)
Includes 197,750 shares of common stock and 750 October 15, 2004 call options held.

(8)
Includes 39,550 shares of common stock and 750 October 15, 2004 call options held.

(9)
Includes 92,457 shares of common stock issuable upon conversion of $2,000,000 in principal amount of .25% Convertible Senior Notes Due 2011 that are not offered by this prospectus.

4




QuickLinks

Prospectus Supplement Dated December 21, 2004 InterMune, Inc. $170,000,000 .25% Convertible Senior Notes Due 2011
SELLING SECURITYHOLDERS